Recital 3, Regulation (EU) 2022/1438

In forcesince 31 Aug 2022

The existing procedures and criteria for the approval set out in Annex II to Regulation (EC) No 1107/2009, which are used to assess whether active substances may have harmful effects on human health, animal health, or unacceptable effects on the environment, are referring to the properties of micro-organisms. Since micro-organisms are living organisms, a specific approach is needed compared to chemical substances, in order to also take into account the currently available scientific knowledge that has been gathered on the biology of micro-organisms, such as on their pathogenicity and infectivity, the possible production of metabolite(s) of concern and the capacity to transfer anti-microbial resistance genes to other micro-organisms which are pathogenic and occurring in European environments, potentially affecting the effectiveness of antimicrobials used in human or veterinary medicine.